Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock - $0.01 Par Value
-
Shares outstanding
-
46,444,122
-
Total 13F shares
-
43,807,927
-
Share change
-
+565,539
-
Total reported value
-
$1,302,667,520
-
Put/Call ratio
-
42%
-
Price per share
-
$29.74
-
Number of holders
-
278
-
Value change
-
+$18,327,231
-
Number of buys
-
105
-
Number of sells
-
97
Institutional Holders of AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value (AVNS) as of Q1 2023
As of 31 Mar 2023,
AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value (AVNS) was held by
278 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
43,807,927 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, RGM Capital, LLC, Paradice Investment Management LLC, STATE STREET CORP, MACQUARIE GROUP LTD, T. Rowe Price Investment Management, Inc., WESTWOOD HOLDINGS GROUP INC, and GOLDMAN SACHS GROUP INC.
This page lists
278
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.